Persistence to edoxaban treatment in patients with atrial fibrillation: Analysis from the Global ETNA-AF program

Back

ESC Professional Premium Access

Persistence to edoxaban treatment in patients with atrial fibrillation: Analysis from the Global ETNA-AF program

Session: Cardioversion, antiarrhythmics and antithrombotic management of atrial fibrillation

Topic: Antiarrhythmic Drug Treatment

Speaker: Associate Professor I. Diemberger (Bologna, IT)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Associate Professor Igor Diemberger

Institute of Cardiology University of Bologna, Bologna (Italy)

5 presentations

0 follower

5 more presentations in this session

A genetic polymorphism on chromosome 4q25 (rs17570669_T) may predict atrial fibrillation recurrence after successful electrical cardioversion

Speaker: Professor T. Ulus (Eskisehir, TR)

Efficacy and safety of antiarrhythmic drugs for pharmacological cardioversion of atrial fibrillation depending on gender: a subanalysis of CANT II Study

Speaker: Associate Professor M. Wybraniec (Katowice, PL)

Intravenous infusion of potassium/magnesium solution for the treatment of postoperative atrial fibrillation after coronary artery bypass graft: a randomized, double-blinded, parallel controlled trial

Speaker: Doctor F. Masoudkabir (Tehran, IR)

Efficacy of bepridil as a periprocedural support drug in atrial fibrillation patients with left ventricular systolic dysfunction undergoing catheter ablation

Speaker: Mr K. Okabe (Fukuoka, JP)

Development of an in vitro platform for transesophageal echocardiographic and color Doppler hemodynamic assessments of left atrial appendage occlusion devices

Speaker: Mr Z. Zhong (Munich, DE)

Access the full session

Cardioversion, antiarrhythmics and antithrombotic management of atrial fibrillation

Speakers: Associate Professor I. Diemberger, Professor T. Ulus, Associate Professor M. Wybraniec, Doctor F. Masoudkabir, Mr K. Okabe...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources